A Review of Coronavirus Disease-2019 (COVID-19)
By: Qurrat ul ain Rana, Mohsin Khan, Abdul Haq, Syed saoud Zaidi, Wasim Sajjad, Anwar Sheed Khan, Sajid Ali, Muhammad Tahir Khan, Muhammad Irfan
Key Words: COVID-2019, Alphacoronavirus, Betacoronavirus, Gammacoronavirus, Deltacoronavirus, Prothrombin time.
Int. J. Biosci. 16(5), 265-279, May 2020.
Certification: ijb 2020 0021 [Generate Certificate]
In today’s world new emerging infectious diseases, particularly those that directly infect respiratory system like Zika virus and severe acute respiratory syndrome (SARS) are posing a major threat to public health. Regardless of intensive research efforts being put, where, when and how these new diseases appear remains in the realm of unknown. A new disease called the coronavirus disease (COVID-19) which adversely affects the respiratory system has been reported recently in China particularly in Wuhan city of Hubei province. The ongoing worldwide outbreak of this disease was declared both pandemic and Public Health Emergency of International Concern by World Health Organization. The International Committee for the taxonomy of Viruses has named this virus as severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). This virus initially originated in bats and then using, yet an unknown intermediary animal was acquired by humans in Wuhan, China in December 2019. There have been around 2,214,327 reported cases of coronavirus disease 2019 (COVID-2019) and 148,889 reported deaths to date (17/04/2020). The transmission of the disease is caused by encountering or inhalation of the infected droplets and the virus has an incubation time ranging from 2 to 14 days. The major symptoms of this disease include sore throat, cough, fever, fatigue, shortness of breath and malaise. Many people also remain asymptomatic. This review article highlights the details about coronavirus, its genome structure, disease, epidemiology, and its treatment.
A Review of Coronavirus Disease-2019 (COVID-19)
Baig AM, Khaleeq A, Ali U, Syeda H. 2020. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms. ACS chemical neuroscience 11(7), 995-998.
Bonavia A, Arbour N, Yong VW, Talbot PJ. 1997. Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43. Journal of virology 71, 800-806.
Burke RM. 2020. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 – United States, January-February 2020. MMWR Morb Mortal Wkly Rep 69, 245-246
Chafekar A, Fielding BC. 2018. MERS-CoV: understanding the latest human coronavirus threat. Viruses 10(2), pii: E93.
Chang Xu H, Rebaza A, Sharma L, Dela Cruz CS. 2020. Protecting health-care workers from subclinical coronavirus infection. Lancet Respiratory Medicine 8, e13
Chen W. 2020. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerging Microbes & Infections 9, 469-473.
Chu H. 2014. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology 454, 197-205.
Corman VM. 2014. Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. Journal of virology 88, 11297-11303.
Day M. 2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. British Medical Journal 368:m1086.
de Groot RJ. 2013. Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. Journal of virology 87, 7790-7792.
Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY. 2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerging microbes & infections 9, 558-570.
Fung TS, Liu DX. 2019. Human Coronavirus: Host-Pathogen Interaction. Annual review of microbiology 73, 529-557.
Graham RL, Donaldson EF, Baric RS. 2013. A decade after SARS: strategies for controlling emerging coronaviruses. Nature Reviews Microbiology 11, 836-848.
Hu B. 2017. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS pathogens. https://doi.org/10.1371/journal.ppat.1006698N.
Hu Z. 2020. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China Science China Life Sciences.
Huang C. 2020 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395, 497-506.
Kakimoto K, Kamiya H, Yamagishi T, Matsui T, Suzuki M, Wakita T. 2020a. Initial investigation of transmission of COVID-19 among crew members during quarantine of a cruise ship—Yokohama, Japan, February 2020. Centers for Disease Control and Prevention 69(11), 312-313.
Kakimoto K, Kamiya H, Yamagishi T, Matsui T, Suzuki M, Wakita T. 2020b. Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship – Yokohama, Japan, February 2020. MMWR Morb Mortal Wkly Rep 69, 312-313
Kendall E, Bynoe M, Tyrrell D. 1962. Virus isolations from common colds occurring in a residential school. British medical journal 2(5297), 82–86.
Lambeir AM, Durinx C, Scharpé S, De Meester I. 2003. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Critical reviews in clinical laboratory sciences 40, 209-294.
Lei J, Li J, Li X, Qi X. 2020. CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 295(1), 18.
Lescure FX. 2020. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infectious Disease
Li J. 2020a. Game consumption and the 2019 novel coronavirus. Lancet Infectious Disease 20(3), 275-276.
Li Z. 2020b. Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis. Journal of Medical Virology 1–7.
Liu Y. 2020. Viral dynamics in mild and severe cases of COVID-19. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(20)302322.
Luk HK, Li X, Fung J, Lau SK, Woo PC. 2019. Molecular epidemiology, evolution and phylogeny of SARS coronavirus. Infection, Genetics and Evolution 71, 21-30.
McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. 1967. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proceedings of the National Academy of Sciences of the United States of America 57(4), 933–940.
McIntosh K, Hirsch MS, Bloom A. 2020. Coronavirus disease 2019 (COVID-19). UpToDate. Hirsch MS, Bloom A (Eds.). Accessed Mar 5.
Peiris J. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. The Lancet 361, 1319-1325.
Pene F. 2003. Coronavirus 229E-related pneumonia in immunocompromised patients. Clinical infectious diseases 37, 929-932.
Perlman S, Netland J. 2009. Coronaviruses post-SARS: update on replication and pathogenesis. Nature reviews microbiology 7, 439-450.
Qian G. 2020. A COVID-19 Transmission within a family cluster by presymptomatic infectors in China. Clinical Infectious Disease
Rothan HA, Byrareddy SN. 2020. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity 109, 102433.
Rothe C. 2020. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N England Journal of Medicine 382, 970-971
Russell CD, Millar JE, Baillie JK. 2020. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395, 473-475.
Sahin AR. 2020. 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. Eurasian Journal of Medicine and Oncology 4, 1-7.
Sheahan TP. 2017. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. S Science translational medicine 28(9), 396. pii: eaal3653.
Singhal T. 2020. A Review of Coronavirus Disease-2019 (COVID-19). Indian Journal of Pediatric 87, 281-286
Tang A. 2020. Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China. Emerging infectious diseases 26.
To KKW. 2020. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases 20(5), 565-574.
Van Doremalen N. 2020. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine 382, 1564-1567.
Wang M. 2020a. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research 30, 269-271.
Wang W. 2020b. Detection of SARS-CoV-2 in different types of clinical specimens. Journal of American Medical Association.
Wertheim JO, Chu DK, Peiris JS, Pond SLK, Poon LL. 2013. A case for the ancient origin of coronaviruses. Journal of Virology 87, 7039-7045.
Wölfel R. 2020. Virological assessment of hospitalized patients with COVID-2019. Nature:1-10
Yu P, Zhu J, Zhang Z, Han Y, Huang L. 2020. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. Journal Infectious Diseases
Zhou F. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395(10229) 1054-1062.
Zhou J. 2014. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. The Journal of infectious diseases 209, 1331-1342.
Zou L. 2020. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine 382, 1177-1179.
A Review of Coronavirus Disease-2019 (COVID-19).
Int. J. Biosci. 16(5), 265-279, May 2020.
By Authors and International Network for
Natural Sciences (INNSPUB)